Investigation Overview
November 16, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of ZS Pharma Inc (NASDAQ:ZSPH), was announced concerning whether the takeover of ZS Pharma Inc. by AstraZeneca for $90 per share is unfair to NASDAQ:ZSPH stockholders. The investigation by a law firm concerns whether certain officers and directors of ZS Pharma Inc breached...
You must register (for free) or login to view the entire investigation.